Allitinib, CAS [[897383-62-9]]

Produktübersicht

• Artikelname: Allitinib, CAS [[897383-62-9]]
• Artikelnummer: BYT-ORB1308633
• Hersteller Artikelnummer: orb1308633
• Alternativnummer: BYT-ORB1308633-1, BYT-ORB1308633-1, BYT-ORB1308633-10, BYT-ORB1308633-100, BYT-ORB1308633-25, BYT-ORB1308633-5, BYT-ORB1308633-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: HER1, Epidermal growth factor receptor, EGFRL858R/T790M, EGFR (T790M/L858R), EGFR, ErbB4, ErbB2, ErbB-1, Irreversible, inhibit, Inhibitor, ALS1306, ALS-1306, Allitinib, anti-cancer, ALS 1306, anilino-quinazoline, AST 1306, AST1306, AST-1306

Produktbeschreibung

Allitinib (AST-1306) is an irreversible, potent inhibitor of EGFR and ErbB2, exhibiting IC50 values of 0.5 nM and 3 nM, respectively. This small molecule is utilized in cancer research, demonstrating antitumor efficacy in both cellular assays and in vivo models of various carcinomas.

Produkteigenschaften

• Molekulargewicht: 448.88
• Reinheit: 99.91% (May vary between batches)
• CAS Nummer: [897383-62-9]
• Formel: C24H18ClFN4O2
• Target-Kategorie: EGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.46 mM),DMSO:55 mg/mL (122.53 mM)